Biotechnology Portfolio Financials
| FBIOX Fund | USD 19.49 0.18 0.93% |
Biotechnology |
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Biotechnology Portfolio Fund Summary
Biotechnology Portfolio competes with Health Care, Technology Portfolio, Fidelity Select, Software, and It Services. The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.Specialization | Health, Large |
| Instrument | USA Mutual Fund View All |
| Exchange | NMFQS Exchange |
| ISIN | US3163907724 |
| Business Address | Fidelity Select Portfolios |
| Mutual Fund Family | Fidelity Investments |
| Mutual Fund Category | Health |
| Benchmark | Dow Jones Industrial |
| Phone | 800 544 8544 |
| Currency | USD - US Dollar |
Biotechnology Portfolio Key Financial Ratios
Biotechnology Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Portfolio's current stock value. Our valuation model uses many indicators to compare Biotechnology Portfolio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotechnology Portfolio competition to find correlations between indicators driving Biotechnology Portfolio's intrinsic value. More Info.Biotechnology Portfolio Biotechnology is one of the top funds in price to earning among similar funds. It also is one of the top funds in price to book among similar funds fabricating about 0.12 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Biotechnology Portfolio Biotechnology is roughly 8.52 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Portfolio's earnings, one of the primary drivers of an investment's value.Biotechnology Portfolio Systematic Risk
Biotechnology Portfolio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biotechnology Portfolio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Biotechnology Portfolio correlated with the market. If Beta is less than 0 Biotechnology Portfolio generally moves in the opposite direction as compared to the market. If Biotechnology Portfolio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biotechnology Portfolio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biotechnology Portfolio is generally in the same direction as the market. If Beta > 1 Biotechnology Portfolio moves generally in the same direction as, but more than the movement of the benchmark.
Biotechnology Portfolio Thematic Clasifications
Biotechnology Portfolio Biotechnology is part of Monster Funds investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Funds with above average long term performance indicators. Solid funds with above average long term performance indicators based on Macroaxis rating system
This theme covers Funds with above average long term performance indicators. Solid funds with above average long term performance indicators based on Macroaxis rating system. Get More Thematic Ideas
Biotechnology Portfolio Biotechnology is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Health category is currently estimated at about 48.03 Billion. Biotechnology Portfolio holds roughly 4.78 Billion in net asset claiming about 10% of all funds under Health category.| Monster Funds | View |
Biotechnology Portfolio February 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biotechnology Portfolio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biotechnology Portfolio Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biotechnology Portfolio Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Biotechnology Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biotechnology Portfolio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 6.56 | |||
| Value At Risk | (3.30) | |||
| Potential Upside | 1.63 |
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |